Table 4 Awareness, treatment and control of dyslipidemia in Chinese adults with previously-diagnosed diabetes and newly-diagnosed diabetes

18-44

8.2 (6.5, 10.3)

3.1 (2.0, 4.7)

-

26.1 (21.6, 31.0)^a

10.6 (7.7, 14.5)^a

12.3 (4.3, 30.9)

45- 64

15.3 (13.8, 17.0)

6.1 (5.1, 7.2)

12.1 (7.4, 19.1)

38.4 (35.5, 41.3)^a

22.3 (19.9, 24.9)^a

17.6 (13.0, 23.5)^b

≥65

15.7 (13.3, 18.4)

8.1 (6.3, 10.4)

12.1 (6.5, 21.3)

32.7 (28.8, 36.7)^a

20.2 (17.0, 23.8)^a

14.0 (8.5, 22.1)

Men

12.1 (10.6, 13.7)

4.2 (3.3, 5.3)

10.5 (6.1, 17.5)

32.4 (29.4, 35.4)^a

16.6 (14.3, 19.1)^a

19.6 (13.8, 27.0)^b

Women

13.7 (12.2, 15.3)

6.8 (5.7, 8.1)

8.7 (4.9, 14.9)

35.7 (32.8, 38.7)^a

21.6 (19.2, 24.2)^a

12.5 (8.6, 17.8)

Urban

18.0 (16.2, 19.9)

6.1 (5.0, 7.3)

6.8 (3.6, 12.5)

36.3 (33.5, 39.2)^a

17.7 (15.6, 20.0)^a

17.1 (12.0, 23.7)^b

Rural

9.8 (8.6, 11.3)

5.0 (4.0, 6.1)

11.3 (6.9, 18.0)

31.4 (28.4, 34.6)^a

20.0 (17.5, 22.8)^a

14.8 (10.2, 21.0)

Underdeveloped

6.6 (5.2, 8.3)

3.3 (2.3, 4.8)

10.2 (3.6, 25.7)

23.8 (19.7, 28.5)^a

13.7 (10.7, 17.3)^a

25.9 (15.3, 40.5)

Intermediately developed

12.7 (10.7, 14.9)

6.9 (5.3, 8.8)

10.3 (5.7, 18.0)

36.6 (32.8, 40.6)^a

23.1 (19.8, 26.7)^a

12.7 (8.0, 19.6)

Developed

18.0 (16.1, 20.0)

5.8 (4.8, 7.1)

8.3 (4.6, 14.5)

36.3 (33.3, 39.3)^a

18.4 (16.1, 20.9)^a

15.3 (10.4, 21.9)

<25.0

7.7 (6.3, 9.4)

3.8 (2.7, 5.2)

10.5 (5.2, 20.0)

26.6 (23.6, 29.8)^a

15.9 (13.5, 18.7)^a

22.0 (15.5, 30.3)^b

25.0-29.9

15.7 (14.0, 17.5)

6.3 (5.2, 7.5)

11.2 (6.8, 17.9)

37.2 (34.1, 40.4)^a

20.6 (18.1, 23.4)^a

13.3 (8.7, 19.7)

≥30.0

17.8 (14.8, 21.3)

6.8 (5.1, 9.2)

2.5 (0.6, 10.1)

46.2 (40.0, 52.9)^a

21.9 (17.2, 27.5)^a

10.4 (4.6, 21.5)

<90 in men, < 80 in women

8.3 (6.8, 10.0)

3.5 (2.4, 4.9)

12.2 (6.2, 22.7)

26.8 (23.5, 30.2)^a

14.6 (12.1, 17.4)^a

25.8 (18.2, 35.2)^b

≥90 in men, ≥ 80 in women

15.7 (14.3, 17.3)

6.6 (5.7, 7.7)

8.6 (5.2, 13.7)

38.5 (35.8, 41.2)^a

21.6 (19.4, 24.0)^a

11.6 (8.0, 16.7)